DeepMed Research

Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane

Not Applicable

Conditions: Epiretinal Membrane

Interventions: Procedure: epiretinal membrane and internal limiting membrane removal

First Posted Date: 2013-11-15

Last Posted Date: 2013-11-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 32

Registration Number: NCT01985490

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Bortezomib Maintenance in High Risk DLBCL

Phase 2

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Bortezomib

First Posted Date: 2013-10-18

Last Posted Date: 2020-10-23

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 59

Registration Number: NCT01965977

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

Phase 2

Completed

Conditions: Primary Mediastinal Large B-cell Lymphoma
Relapsed or Refractory Hodgkin Lymphoma

Interventions: Drug: Ruxolitinib

First Posted Date: 2013-10-18

Last Posted Date: 2018-11-01

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 20

Registration Number: NCT01965119

Locations: 🇰🇷
Wonju Severance Christian Hospital, Wonju, Korea, Republic of
🇰🇷
Dong-A University, Busan, Korea, Republic of
🇰🇷
Busan University Hospital, Busan, Korea, Republic of

and more 4 locations

Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients

Completed

Conditions: Bladder Pain Syndrome

Interventions: Procedure: Transurethral Coagulation (TUC)
Procedure: Transurethral Resection(TUR)

First Posted Date: 2013-10-17

Last Posted Date: 2017-12-14

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 126

Registration Number: NCT01963988

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis

Not Applicable

Terminated

Conditions: Hyperthermia

Interventions: Radiation: Combined hyperthermia and radiation therapy

First Posted Date: 2013-10-16

Last Posted Date: 2020-03-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 11

Registration Number: NCT01963117

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Zydena on Cognitive Function of Alzheimer's Disease Patients

Phase 3

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo + Donepezil 5mg or 10mg
Drug: Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg
Drug: Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg

First Posted Date: 2013-09-12

Last Posted Date: 2013-09-12

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 210

Registration Number: NCT01940952

Locations: 🇰🇷
Samguns Medical Center, Seoul, Korea, Republic of

Patients Who Refractory Cancer Conqueror for Bio New Drug Development Translational Research Establishment

Conditions: Refractory Cancer

First Posted Date: 2013-08-30

Last Posted Date: 2013-08-30

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1523

Registration Number: NCT01932047

Locations: 🇰🇷
Samsung Medical Center, Seoul, Gyunggido, Korea, Republic of

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

Early Phase 1

Completed

Conditions: Histologically Proven Extranodal NKTcell Lymphoma

Interventions: Drug: Romidepsin

First Posted Date: 2013-07-31

Last Posted Date: 2013-07-31

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 16

Registration Number: NCT01913119

Locations: 🇰🇷
Asan Medical Center, Songpa-gu, Seoul, Korea, Republic of
🇰🇷
Severance Hospital, Seodaemun-gu, Seoul, Korea, Republic of
🇰🇷
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of

and more 1 locations

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma

Not Applicable

Completed

Conditions: Localized Non-Resectable Adult Hepatocellular Carcinoma

Interventions: Radiation: Stereotactic body radiotherapy

First Posted Date: 2013-07-30

Last Posted Date: 2023-11-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 56

Registration Number: NCT01910909

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis

Phase 2

Completed

Conditions: Carcinoma. Hepatocellular

Interventions: Radiation: RT and hyperthermia after TACE

First Posted Date: 2013-07-30

Last Posted Date: 2016-08-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 69

Registration Number: NCT01911000

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy